商品情報にスキップ
1 2

GlaxoSmithKline Pharmaceuticals Ltd.: Reinventing Incentives and Performance

通常価格 ¥1,276 JPY
通常価格 セール価格 ¥1,276 JPY
セール 売り切れ
税込み。
書籍サイズ
ページ数

In 2015, GlaxoSmithKline (GSK) moved from target-driven sales, to a no-sales target regime. This change involved the sales incentives plan and performance measurement parameters of the front line medical sales force of the company. The executive director of Human Resources knew that challenges lay ahead in managing the company's employees and reinvigorating the values of the organization. He was hoping to shift the focus of the sales force to ethical behaviour, dissemination of scientific knowledge among doctors, and customer and patient care. Many people were adapting to the new system while a few resisted, and some left the organization. Though management anticipated this turn of events and accepted the employee turnover, the director knew that more work needed to be done to make the new system more acceptable and functional. How should he address the subjectivity of the system, simplify it for his salesforce, and address the concerns of his managers? Would the new system motivate performance? Could he convince his employees of the potential benefits of the process- and competence-based pay system at GSK? Hema Bajaj is affiliated with NMIMS University. Manjari Srivastava is affiliated with NMIMS University.

【書誌情報】

ページ数:18ページ

サイズ:A4

商品番号:HBSP-W19580

発行日:2019/10/7

登録日:2020/1/23

1 3